299 related articles for article (PubMed ID: 17197180)
21. Synthesis of 2-alkoxy 1,4-naphthoquinone derivatives as antiplatelet, antiinflammatory, and antiallergic agents.
Lien JC; Huang LJ; Teng CM; Wang JP; Kuo SC
Chem Pharm Bull (Tokyo); 2002 May; 50(5):672-4. PubMed ID: 12036028
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of N1-substituted benzamidines. Effects on blood coagulation, platelet aggregation and antiarrhythmic activity.
Ferroni R; Simoni D; Manfredini S; Guarneri M; Orlandini P; Barbieri M; Franzè GP; Mugelli A
Arzneimittelforschung; 1995 Jun; 45(6):665-9. PubMed ID: 7646567
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and evaluation of benzoxazinone derivatives on activity of human neutrophil elastase and on hemorrhagic shock-induced lung injury in rats.
Hsieh PW; Yu HP; Chang YJ; Hwang TL
Eur J Med Chem; 2010 Jul; 45(7):3111-5. PubMed ID: 20417587
[TBL] [Abstract][Full Text] [Related]
24. Influence of combinations of acetylsalicylic acid, acetaminophen, and diclofenac on platelet aggregation.
Galliard-Grigioni KS; Fehr M; Reinhart WH
Eur J Pharmacol; 2008 Oct; 595(1-3):65-8. PubMed ID: 18700139
[TBL] [Abstract][Full Text] [Related]
25. A comparative optical aggregometry study of antiplatelet activity of taxanes from Taxus cuspidata.
Kim SY; Yun-Choi HS
Thromb Res; 2010 Jun; 125(6):e281-4. PubMed ID: 20170941
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of 2H-benzo[b][1,4]oxazin-3(4H)-one derivatives as platelet aggregation inhibitors.
Tian X; Wang LY; Xia S; Li ZB; Liu XH; Yuan Y; Fang L; Zuo H
Bioorg Med Chem Lett; 2012 Jan; 22(1):204-6. PubMed ID: 22137848
[TBL] [Abstract][Full Text] [Related]
27. Effects of ibuprofen on the magnitude and duration of aspirin's inhibition of platelet aggregation: clinical consequences in stroke prophylaxis.
Gengo FM; Rubin L; Robson M; Rainka M; Gengo MF; Mager DE; Bates V
J Clin Pharmacol; 2008 Jan; 48(1):117-22. PubMed ID: 18094224
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and inhibitory effects of 2-pyridyl-2-thiobenzoxazole and 2-pyridyl-2-thiobenzimidazole derivatives on arachidonic acid metabolism.
Lagorce JF; Fatimi J; Lakhdar M; Chabernaud ML; Buxeraud J; Raby C
Arzneimittelforschung; 1995 Nov; 45(11):1207-10. PubMed ID: 8929241
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and inhibitory effects of 1,2,4-triazole derivatives on platelet aggregation.
Lagorce JF; Moulard T; Raby C
Arzneimittelforschung; 1992 Mar; 42(3):314-8. PubMed ID: 1497691
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and evaluation of platelet aggregation inhibitory activity of some 3-phenyl-pyrroloquinazolinones.
Ferlin MG; Borgo C; Deana R
Eur J Med Chem; 2012 Feb; 48():275-83. PubMed ID: 22236469
[TBL] [Abstract][Full Text] [Related]
31. Gingerols and related analogues inhibit arachidonic acid-induced human platelet serotonin release and aggregation.
Koo KL; Ammit AJ; Tran VH; Duke CC; Roufogalis BD
Thromb Res; 2001 Sep; 103(5):387-97. PubMed ID: 11553371
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and anti-platelet activity of obovatol derivatives.
Kwak JH; Lee S; Park ES; In JK; Song J; Kim YJ; Choi NS; Lee H; Yun YP; Hong JT; Kwak YS; Min KH; Jung JK
Arch Pharm Res; 2011 Jul; 34(7):1107-12. PubMed ID: 21811917
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and antiplatelet activity of new imidazole-4-carboxylic acid derivatives.
Rehse K; Steege J
Arch Pharm (Weinheim); 2005 Nov; 338(11):539-47. PubMed ID: 16281307
[TBL] [Abstract][Full Text] [Related]
34. Anti-inflammatory and anti-platelet aggregation activity of human placental extract.
Sur TK; Biswas TK; Ali L; Mukherjee B
Acta Pharmacol Sin; 2003 Feb; 24(2):187-92. PubMed ID: 12546729
[TBL] [Abstract][Full Text] [Related]
35. Screening of anti-platelet aggregation agents from Panax notoginseng using human platelet extraction and HPLC-DAD-ESI-MS/MS.
Wang J; Huang ZG; Cao H; Wang YT; Hui P; Hoo C; Li SP
J Sep Sci; 2008 Apr; 31(6-7):1173-80. PubMed ID: 18381690
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and platelet aggregation inhibitory effects of N-[(1H-pyrazol-1-yl)alkyl]benzoylamides.
Ferroni R; Milani L; Simoni D; Orlandini P; Bottura M; Bardi A; Guarneri M
Arzneimittelforschung; 1990 Jun; 40(6):705-9. PubMed ID: 2397007
[TBL] [Abstract][Full Text] [Related]
37. Pyran derivatives XIX. (Dialkylamino) substituted 1-benzopyranones and naphthopyranones with platelet antiaggregating activity.
Di Braccio M; Roma G; Leoncini G; Poggi M
Farmaco; 1995 Oct; 50(10):703-11. PubMed ID: 8590578
[TBL] [Abstract][Full Text] [Related]
38. Ethyl or methyl 6-substituted 3-(benzoylamino)-2-oxo-2H-pyran-5-carboxylates and 3-(benzoylamino)-7,8-dihydro-2H-1-benzopyran-2,5(6H)-diones with local anesthetic, platelet antiaggregating and other activities.
Mosti L; Menozzi G; Schenone P; D'Amico M; Falciani M; Rossi F
Farmaco; 1994 Jan; 49(1):45-50. PubMed ID: 8185749
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effect of pyridyloxy- or phenoxylphenoxyalkanate derivatives on rat lens aldose reductase and rat platelet aggregation.
Lim SS; Shin KH; Jung SH; Shin KJ; Kim DC; Park SW; Shin HK; Keum SR
J Pharm Pharmacol; 2004 Jul; 56(7):941-5. PubMed ID: 15233875
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, antiplatelet and vasorelaxing activities of xanthone derivatives.
Lin KW; Fang SC; Hung CF; Shieh BJ; Yang SC; Teng CM; Lin CN
Arch Pharm (Weinheim); 2009 Jan; 342(1):19-26. PubMed ID: 19035386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
